Company intelligence / Profile preview

Titan Spine

Mequon, Wisconsin, United Statesturnkeytec.com ↗

Ownership: Private
Development stage: Commercial

Overview

Titan Spine developed and commercialized titanium interbody spinal fusion implants with proprietary macro/micro/nano-textured surfaces designed to promote bone growth and improve patient outcomes. The company received multiple FDA clearances, including the first for a nanotechnology-enhanced device. Over its history, more than 70,000 devices were implanted worldwide before being acquired by Medtronic in June 2019. Clinical studies suggested superior performance compared to PEEK-based devices.

Therapeutic areas: Neurology
Modalities: Device (specifically spinal interbody fusion implants)Nanotechnology surface modification (for bone growth promotion)
Industry: Implantable Medical Devices

Partnerships

none specifically reported pre-acquisition; post-acquisition integrated into Medtronic’s partnerships network.

Beyond the preview

Go deeper on Titan Spine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Titan Spine.

Explore the full profile